While VEGFB released from tumors is known to augment pain sensitivity through selective activation of VEGFR1 expression in peripheral sensory neurons in cancer pain models29, the present study for the first time illustrated the functional significance of spinal neuron-derived VEGFB in the central sensitization to neuropathic pain induced by spinal nerve injury. This evidence concerns the gene FLT1 and cancer.